Science Explorer Interactive view Map
Nonprofit · Indianapolis · United States

Indiana Cancer Consortium

In research, Indiana Cancer Consortium stands highest in Medicine (#9,761 of 17,978 worldwide) and Health Sciences (#12,730 of 20,462 worldwide), over all time.

indianacancer.orgROR OpenAlex
World rank, 2022–2025
#13,629
of 28,054 · #18,610 all time
Rank in United States
#1,892
of 4,192
Research works
285
▲ 7% vs 2013–17
Citations
9.5k
33.3 per fractional work
Top-10% rate
25.4%
record average 16.5%
Open access
56%
world 28%

What is Indiana Cancer Consortium known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #9,761 of 17,978 24.8%174
Health SciencesDomain #12,730 of 20,462 24.3%180

Each strip is that field’s whole ranked pool, with the notch where Indiana Cancer Consortium sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.43× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 5.64× its world share, 4 worksImmunology and Micro…Neuroscience: 0.95× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.10× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.25× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Engineering: 0.09× its world share, 1 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 0.33× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.50× its world share, 1 worksHealth ProfessionsMedicine: 3.14× its world share, 39 worksMedicineNursing: 0.25× its world share, 0 worksNursingBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.07× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.29× its world share, 0 worksEconomics, Econometr…Psychology: 0.25× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.6×. Every wedge is a field page.

Which keywords describe research at Indiana Cancer Consortium?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Cancer, Tumor Microenvironment, Targeted Therapy, Prognostic Factors, Risk Factors and Cancer Incidence.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy7▲ 15×15 topics
  2. Chemotherapy6▲ 14×19 topics
  3. Cancer5▲ 5.9×40 topics
  4. Inflammation4▲ 2.9×32 topics
  5. Risk Factors3▲ 4.9×6 topics
  6. Tumor Microenvironment3▲ 11×6 topics
  7. Targeted Therapy3▲ 22×5 topics
  8. Prognostic Factors3▲ 9.9×9 topics
  9. Clinical Trials3▲ 6.2×8 topics
  10. Cancer Incidence3▲ 30×4 topics
  11. Radiotherapy3▲ 11×7 topics
  12. Staging System3▲ 67×2 topics
  13. Cancer Immunotherapy2▲ 26×3 topics
  14. Cancer Therapy2▲ 6.7×13 topics
  15. Metastasis2▲ 11×12 topics
  16. Breast Cancer2▲ 15×10 topics
  17. Gene Expression2▲ 5.6×10 topics
  18. Minimal Residual Disease2▲ 50×2 topics
  19. Prognosis2▲ 10×5 topics
  20. Genetic Mutations2▲ 7.6×9 topics
  21. Proteasome Inhibitors2▲ 46×2 topics
  22. Tumor Regression2▲ 29×2 topics
  23. Lymphoma2▲ 19×2 topics
  24. Mortality Rates2▲ 32×2 topics
  25. Population-Based Study2▲ 49×2 topics
  26. Survival Analysis2▲ 11×6 topics
  27. Breast Cancer Screening2▲ 65×1 topic
  28. Clinical Practice Guidelines2▲ 5.5×9 topics
  29. Diagnosis Criteria2▲ 82×1 topic
  30. Global Surveillance2▲ 65×1 topic
  31. Health Disparities2▲ 12×2 topics
  32. International Myeloma Working Group2▲ 82×1 topic
  33. Molecular Classification2▲ 20×3 topics
  34. Immune Checkpoint Blockade2▲ 25×1 topic
  35. PD-1 and PD-L12▲ 25×1 topic
  36. CAR T Cells2▲ 36×1 topic
  37. Chimeric Antigen Receptor2▲ 36×1 topic
  38. Immunity2▲ 6.6×6 topics
  39. Cell Proliferation2▲ 26×4 topics
  40. Epigenetic Regulation1▲ 10×4 topics

Which research topics does Indiana Cancer Consortium publish most on?

By volume in 2022–2025: Global Cancer Incidence and Screening, Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Global Cancer Incidence …2Global Cancer Incidence and Screening: 2 fractional worksMultiple Myeloma Researc…2Multiple Myeloma Research and Treatments: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksCancer Genomics and Diagnostics: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksGlioma Diagnosis and Tre…1Glioma Diagnosis and Treatment: 1 fractional worksMyasthenia Gravis and Thymoma: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksSingle-cell and spatial transcriptomics: 1 fractional works
OncologyHematologyCancer ResearchPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 2 works
  2. 2 Multiple Myeloma Research and Treatments Hematology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 1 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  7. 7 Glioma Diagnosis and Treatment Genetics 1 works
  8. 8 Myasthenia Gravis and Thymoma Neurology 1 works
  9. 9 Immune Cell Function and Interaction Immunology 1 works
  10. 10 Single-cell and spatial transcriptomics Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.5%not open44.5%

World: 28% of research is openly available.

with international co-authors19.9%domestic only80.1%

World: 19% is written across borders.

How has Indiana Cancer Consortium's research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Indianapolis

All research institutions in Indianapolis

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.